BTSG vs. MDLN: BrightSpring Health Services vs. Medline Stock Comparison

Company Profile

BrightSpring Health Services (BTSG) and Medline (MDLN) both fall under the Health Care Equipment & Services industry group, but BTSG is classified in Health Care Providers & Services while MDLN is classified in Health Care Equipment & Supplies.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. BrightSpring Health Services (BTSG) has a non-negative beta of 1.75.

Risk-Adjusted Performance

Risk-Return Positioning

Both BTSG and MDLN need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

BrightSpring Health Services (BTSG) at 15.54% sits in the top ROE quartile, while Medline (MDLN) at 4.85% is closer to the peer norm — stronger capital efficiency for BTSG.

Both BrightSpring Health Services (BTSG) at 2.69% and Medline (MDLN) at 1.85% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Both BrightSpring Health Services (BTSG) at 3.81% and Medline (MDLN) at 5.22% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Only one side can be read here: BrightSpring Health Services (BTSG) reports revenue growth of 28.18%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Only one side can be read here: Medline (MDLN) reports EPS growth of 117.38%, ranked against its industry; BrightSpring Health Services (BTSG) has no EPS growth figure this period.

Growth Metrics

Financial Strength

BrightSpring Health Services (BTSG) at 1.62 keeps current ratio within its industry’s typical mid-range, while Medline (MDLN) at 4.04 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Medline (MDLN) at 0.65 carries an industry-typical debt-to-equity mix, while BrightSpring Health Services (BTSG) at 1.09 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Neither BrightSpring Health Services (BTSG) nor Medline (MDLN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither BrightSpring Health Services (BTSG) nor Medline (MDLN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

BrightSpring Health Services (BTSG) at 47.62 is near its industry’s usual P/E ratio, while Medline (MDLN) at 90.09 sits above its peer range — an unusually expensive price for MDLN’s trailing earnings.

BrightSpring Health Services (BTSG) at 0.88 sits in the cheaper P/S ratio quartile while Medline (MDLN) at 1.70 prices around its industry’s middle — BTSG costs less per dollar of sales, though read it alongside growth and margins.

Medline (MDLN) at 2.95 is valued about in line with its industry on P/B ratio, while BrightSpring Health Services (BTSG) at 6.39 carries an above-peer premium to book — BTSG is pricier on assets.

Valuation Metrics